Skip to main content
Log in

Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro

  • Note
  • Published:
Journal of Natural Medicines Aims and scope Submit manuscript

Abstract

Eurycomanone, an active constituent isolated from Eurycoma longifolia Jack, was examined for modulatory effects on cytochrome P450 (CYP) isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 using in vitro assays. The IC50 value was determined to assess the potencies of modulation for each CYP isoform. Our results indicated that eurycomanone did not potently inhibit any of the CYP isoforms investigated, with IC50 values greater than 250 μg/ml. Hence there appears to be little likelihood of drug–herb interaction between eurycomanone or herbal products with high content of this compound and CYP drug substrates via CYP inhibition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bhat R, Karim AA (2010) Tongkat Ali (Eurycoma longifolia Jack): a review on its ethnobotany and pharmacological importance. Fitoterapia 81:669–679

    Article  PubMed  Google Scholar 

  2. Kardono LBS, Angerhofer CK, Tsauri S, Padmawinata K, Pezzuto JM, Kinghorn AD (1991) Cytotoxic and antimalarial constituents of the roots of Eurycoma longifolia. J Nat Prod 54:1360–1367

    Article  CAS  PubMed  Google Scholar 

  3. Gimlette JD, Thomson HW (1977) A dictionary of Malayan medicine. Oxford University Press, Kuala Lumpur

    Google Scholar 

  4. Perry LM, Metzger J (1980) Medicinal plants of East and Southeast Asia: attributed properties and uses. Massachusetts Institute of Technology Press, MA

    Google Scholar 

  5. Ismail Z, Ismail N, Lassa J (1999) Malaysian herbal monograph. Malaysian Monograph Committee, Kuala Lumpur

  6. Jagananth JB, Ng LT (2000) Herbs—the green pharmacy of Malaysia. Malaysian Agricultural Research and Development Institute (MARDI), Kuala Lumpur

  7. Nurkhasanah M, Azimahtol HLP (2008) Eurycomanone induces apoptosis through the up-regulation of p53 in human cervical carcinoma cells. J Cancer Mol 4:109–115

    Google Scholar 

  8. Wong PF, Cheong WF, Shu MH, Teh CH, Chan KL, Abu Bakar S (2012) Eurycomanone suppresses expression of lung cancer cell tumor markers, prohibition, annexin 1 and endoplasmic reticulum protein 28. Phytomedicine 19:138–144

    Article  CAS  PubMed  Google Scholar 

  9. Zakaria Y, Rahmat A, Pihie AH, Abdullah NR, Houghton PJ (2009) Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53. Cancer Cell Int 9:16

    Article  PubMed Central  PubMed  Google Scholar 

  10. Teh CH, Abdulghani M, Morita H, Shiro M, Hussin AH, Chan KL (2011) Comparative X-ray and conformational analysis of a new crystal of 13α, 21-dihydroeurycomanone with eurycomanone from Eurycoma longifolia and their anti-estrogenic activity using the uterotrophic assay. Planta Med 77:128–132

    Article  CAS  PubMed  Google Scholar 

  11. Chan KL, Choo CY, Abdullah NR (2005) Semisynthetic 15-O-acyl- and 1,15-di-O-acyleurycomanones from Eurycoma longifolia as potential antimalarials. Planta Med 71:967–969

    Article  CAS  PubMed  Google Scholar 

  12. Degtyarenko KN, Archakov AI (1993) Molecular evolution of P450 superfamily and P450-containing monooxygenase systems. FEBS Lett 332:1–8

    Article  CAS  PubMed  Google Scholar 

  13. Miller DM, Helms SE, Brodell RT (1994) A practical approach to antibiotic treatment in women taking oral contraceptives. J Am Acad Dermatol 30:1008–1011

    Article  CAS  PubMed  Google Scholar 

  14. Heimark LD, Wienkers L, Kunze K, Gibaldi M, Eddy AC, Trager WF, O’Reilly RA, Goulart DA (1992) The mechanism of the interaction between amiodarone and warfarin in humans. Clin Pharmacol Ther 51:398–407

    Article  CAS  PubMed  Google Scholar 

  15. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 289:1569–1575

    Article  Google Scholar 

  16. Tindle HA, Davis RB, Phillips RS, Eisenberg DM (2005) Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med 11:42–49

    PubMed  Google Scholar 

  17. Su D, Li L (2011) Trends in the use of complementary and alternative medicine in the United States: 2002–2007. J Health Care Poor Underserved 22:296–310

    PubMed  Google Scholar 

  18. Shields M, Niazi U, Badal S, Yee T, Sutcliffe MJ, Delgoda R (2009) Inhibition of CYP1A1 by quassinoids found in Picrasma excelsa. Planta Medica 75:137–141

    Article  CAS  PubMed  Google Scholar 

  19. Pan Y, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Ong CE (2011) Heterologous expression of human cytochromes P450 2D6 and CYP3A4 in Escherichia coli and their functional characterization. Protein J 30:581–591

    Article  CAS  PubMed  Google Scholar 

  20. Pan Y, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Pook PC, Er HM, Ong CE (2010) In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica. J Ethnopharmacol 130:275–283

    Article  CAS  PubMed  Google Scholar 

  21. Pan Y, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Pook PC, Er HM, Ong CE (2011) In vitro modulatory effects of Andrographis paniculata, Centella asiatica and Orthosiphon stamineus on cytochrome P450 2C19 (CYP2C19). J Ethnopharmacol 133:881–887

    Article  PubMed  Google Scholar 

  22. Ghosal A, Hapangama N, Yuan Y, Lu X, Horne D, Patrick JE, Zbaida S (2003) Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes. Biopharm Drug Dispos 24:375–384

    Article  CAS  PubMed  Google Scholar 

  23. Wilkinson JT, Fraunfelder FW (2011) Use of herbal medicines and nutritional supplements in ocular disorders: an evidence-based review. Drugs 71:2421–2434

    Article  CAS  PubMed  Google Scholar 

  24. Breidenbach T, Hoffmann MW, Becker T, Schlitt H, Klempnauer J (2000) Drug interaction of St John’s wort with cyclosporin. Lancet 355:1912

    Article  CAS  PubMed  Google Scholar 

  25. Delgoda R, Westlake AC (2004) Herbal interactions involving cytochrome P450 enzymes: a mini review. Toxicol Rev 23:239–249

    Article  CAS  PubMed  Google Scholar 

  26. Low BS, Ng BH, Choy WP, Yuen KH, Chan KL (2005) Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia. Planta Med 71:803–807

    Article  CAS  PubMed  Google Scholar 

  27. Salman SA, Amrah S, Wahab MS, Ismail Z, Ismail R, Yuen KH, Gan SH (2010) Modification of propranolol’s bioavailability by Eurycoma longifolia water-based extract. J Clin Pharm Ther 35:691–696

    Article  CAS  PubMed  Google Scholar 

  28. Low BS, Teh CH, Yuen KH, Chan KL (2011) Physico-chemical effects of the major quassinoids in a standardized Eurycoma longifolia extract (Fr 2) on the bioavailability and pharmacokinetic properties, and their implications for oral antimalarial activity. Nat Prod Commun 6:337–341

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank the Malaysian Ministry of Science, Technology and Innovation (Grant: eScienceFund 02-02-09-SF0005) for kind funding and support given to this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chin Eng Ong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pan, Y., Tiong, K.H., Abd-Rashid, B.A. et al. Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro. J Nat Med 68, 402–406 (2014). https://doi.org/10.1007/s11418-013-0794-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11418-013-0794-8

Keywords

Navigation